Novel STAT3 Inhibitor LDOC1 Targets Phospho-JAK2 for Degradation by Interacting with LNX1 and Regulates the Aggressiveness of Lung Cancer

• Published in: Cancers Vol. 11; no. 1; p. 63
• Main Authors: Lee, Chia-Huei, Yang, Ji-Rui, Chen, Chih-Yu, Tsai, Ming-Hsien, Hung, Pin-Feng, Chen, Shin-Jih, Chiang, Shang-Lun, Chang, Han, Lin, Pinpin
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 09.01.2019; MDPI
• Subjects: Adenocarcinoma; Cell cycle; Cigarette smoke; Cigarettes; Confocal microscopy; DNA methylation; Gene expression; Immunohistochemistry; Immunoprecipitation; Interleukin 6; Janus kinase 2; Leucine zipper proteins; Lung cancer; Lung carcinoma; Malignancy; Medical prognosis; Non-small cell lung carcinoma; Patients; Phenotypes; Phosphorylation; Proteasomes; Proteins; Stat3 protein; Tumor cell lines; Tumorigenesis; Ubiquitin; Ubiquitin-protein ligase; Ubiquitination; lung cancer; LNX1; LDOC1; JAK2; ubiquitination; STAT3
• DOI: 10.3390/cancers11010063
• ISSN: 2072-6694

Meta-analysis revealed that Leucine Zipper Down-Regulated In Cancer 1 (LDOC1) increased methylation more in people with lung tumors than in those who were healthy and never smoked. Quantitative methylation-specific PCR revealed that cigarette smoke condensate (CSC) exposure drives LDOC1 promoter hypermethylation and silence in human bronchial cells. Immunohistochemistry studies showed that LDOC1 downregulation is associated with poor survival of patients with lung cancer. Loss and gain of LDOC1 functions enhanced and attenuated aggressive phenotypes in lung adenocarcinoma A549 and non–small cell lung carcinoma H1299 cell lines, respectively. We found that LDOC1 deficiency led to reinforcing a reciprocal loop of IL-6/JAK2/STAT3, through which LDOC1 mediates the cancer progression. LDOC1 knockdown considerably augmented tumorigenesis and the phosphorylation of JAK2 and STAT3 in vivo. Results from immunoprecipitation and immunofluorescent confocal microscopy indicated that LDOC1 negatively regulates JAK2 activity by forming multiple protein complexes with pJAK2 and E3 ubiquitin-protein ligase LNX1, and in turn, LDOC1 targets pJAK2 to cause ubiquitin-dependent proteasomal degradation. LDOC1 deficiency attenuates the interactions between LNX1 and pJAK2, leading to ineffective ubiquitination of pJAK2, which activates STAT3. Overall, our results elucidated a crucial role of LDOC1 in lung cancer and revealed how LDOC1 acts as a bridge between tobacco exposure and the IL-6/JAK2/STAT3 loop in this human malignancy.